Financial Challenges for Cancer Survivors Facing High-Cost Immunotherapies, Especially Blood Cancer Patients
New research uncovers the financial hardships faced by cancer survivors, especially those with blood cancers, due to the rising costs of immunotherapy treatments. The study highlights the need for better support systems to ensure treatment accessibility.
A recent study published in the Journal of Cancer Survivorship highlights the significant financial burdens faced by cancer survivors undergoing expensive immunotherapy treatments. The research reveals that these high-cost therapies, despite their clinical benefits, can lead to increased financial hardship, making it difficult for patients to afford ongoing care and medications. Notably, blood cancer survivors, such as those with leukemia or lymphoma, are disproportionately affected, experiencing a nearly 24 percentage point rise in inability to pay for medical care and a 43 percentage point increase in medication non-adherence due to cost constraints.
The study focused on Medicare-enrolled older adults who received infusion or oral immunotherapies between 2010 and 2020, emphasizing the growing prevalence and costs of these treatments. Senior author Cathy Bradley from the Colorado School of Public Health emphasizes the importance of understanding whether insured patients can truly afford their treatments as drug prices continue to climb.
While it is known that many cancer patients face financial difficulties, this research specifically underscores the strain caused by immunotherapy, a key breakthrough in oncology. The findings suggest that even insured patients struggle with out-of-pocket expenses, a concern that is especially pressing for blood cancer survivors who experience greater economic challenges.
The results call for urgent policy and support interventions to reduce the financial barriers to essential cancer treatments. Addressing these issues is crucial to ensuring that patients do not have to choose between financial stability and vital medication adherence, ultimately aiming to improve access to lifesaving therapies.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
The Extensive Impact of Dementia on American Families
A new study reveals that over a quarter of families with older adults in the U.S. include someone living with dementia, highlighting the disease's widespread impact on family life and caregiving networks.
Responsive Parenting Strategies Can Reduce Childhood Obesity-Related Behaviors
Early responsive parenting practices can significantly reduce behaviors linked to childhood obesity, helping families foster healthier growth from infancy.
Major Challenges in Conducting Multinational Clinical Trials in Europe Uncovered
A new study uncovers significant ethical, regulatory, and logistical hurdles faced during European multinational clinical trials, highlighting the need for harmonized processes to accelerate research, especially during health crises.
Rising Concerns Over Unverified Lyme Disease Tests and Treatments
Unapproved tests and unproven treatments for Lyme disease are proliferating, risking patients’ health and financial well-being. Experts urge caution and reliance on validated medical practices.